• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues].

作者信息

Tomonaga Masao

出版信息

Rinsho Ketsueki. 2009 Oct;50(10):1401-6.

PMID:19915348
Abstract
摘要

相似文献

1
[Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues].[世界卫生组织造血与淋巴组织肿瘤分类修订版的大纲与方向]
Rinsho Ketsueki. 2009 Oct;50(10):1401-6.
2
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.2008年世界卫生组织造血与淋巴组织肿瘤分类概述
Pathologica. 2010 Jun;102(3):83-7.
3
The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.免疫表型和基因分型研究在造血与淋巴组织肿瘤诊断及分类中的应用。最新进展。
Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S13-39.
4
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.综述系列介绍：《世界卫生组织造血与淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2361-4. doi: 10.1182/blood-2016-03-657379. Epub 2016 Apr 11.
5
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.世界卫生组织造血与淋巴组织肿瘤性疾病分类。进展报告。
Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S8-12.
6
Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
Anticancer Res. 2003 Mar-Apr;23(2A):1139-48.
7
[From FAB and REAL to WHO as comprehensive classification for hematopoietic and lymphoid tissues].[从FAB和REAL分类到WHO造血与淋巴组织综合分类]
Nihon Rinsho. 2007 Jan 28;65 Suppl 1:233-40.
8
2016 WHO Classification update-What's new in lymphoid neoplasms.2016年世界卫生组织分类更新——淋巴肿瘤的新内容。
Int J Lab Hematol. 2017 May;39 Suppl 1:14-22. doi: 10.1111/ijlh.12650.
9
[From FAB classification to WHO classification of tumors of hematopoietic and lymphoid tissue].[从造血与淋巴组织肿瘤的FAB分类到世界卫生组织（WHO）分类]
Rinsho Byori. 2012 Jun;60(6):550-2.
10
The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.骨髓增殖性肿瘤：对分子发病机制的见解以及世界卫生组织分类和诊断标准的变化
Hematol Oncol Clin North Am. 2009 Aug;23(4):693-708. doi: 10.1016/j.hoc.2009.04.002.

引用本文的文献

1
Immunoglobulin G4 Smoldering Multiple Myeloma With Immunoglobulin G4-Related Autoimmune Hepatitis: A Rare Case Report.伴有免疫球蛋白G4相关自身免疫性肝炎的免疫球蛋白G4冒烟型多发性骨髓瘤：一例罕见病例报告
Immun Inflamm Dis. 2025 Aug;13(8):e70244. doi: 10.1002/iid3.70244.
2
Clinical analysis of 10 cases with subcutaneous panniculitis-like T-cell lymphoma and tissue AURKA expression.皮下脂膜炎样 T 细胞淋巴瘤及组织 AURKA 表达 10 例临床分析。
Skin Res Technol. 2024 Aug;30(8):e13899. doi: 10.1111/srt.13899.
3
Glycosylation: mechanisms, biological functions and clinical implications.
糖基化：机制、生物学功能和临床意义。
Signal Transduct Target Ther. 2024 Aug 5;9(1):194. doi: 10.1038/s41392-024-01886-1.
4
A comprehensive review of the literature on CD10: its function, clinical application, and prospects.关于CD10的文献综述：其功能、临床应用及前景
Front Pharmacol. 2024 Feb 8;15:1336310. doi: 10.3389/fphar.2024.1336310. eCollection 2024.
5
Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia.儿童急性淋巴细胞白血病的异基因造血干细胞移植
Ann Hematol. 2024 Jan;103(1):297-305. doi: 10.1007/s00277-023-05506-w. Epub 2023 Nov 22.
6
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells.基质金属蛋白酶9相关肿瘤干细胞、CCL1沉默的树突状细胞和细胞因子诱导的杀伤细胞通过激活T细胞对急性髓系白血病具有显著的治疗效果。
Stem Cells Int. 2023 May 9;2023:2490943. doi: 10.1155/2023/2490943. eCollection 2023.
7
Transforming B cell lymphoma: A diagnostic dilemma.转化性B细胞淋巴瘤：诊断难题。
J Oral Maxillofac Pathol. 2020 May-Aug;24(2):202-203. doi: 10.4103/jomfp.JOMFP_143_20. Epub 2020 Sep 9.
8
Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma.微小RNA-130a的过表达预示着原发性胃肠道弥漫性大B细胞淋巴瘤的不良预后。
Oncol Lett. 2020 Oct;20(4):93. doi: 10.3892/ol.2020.11954. Epub 2020 Aug 6.
9
miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma.微小RNA-150是原发性胃肠道弥漫性大B细胞淋巴瘤的一种独立的负性预后生物标志物。
Oncol Lett. 2020 May;19(5):3487-3494. doi: 10.3892/ol.2020.11452. Epub 2020 Mar 10.
10
The Impact of Surgery on Long-Term Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: A SEER Population-Based Study.手术对原发性胃弥漫性大B细胞淋巴瘤患者长期生存的影响：一项基于监测、流行病学和最终结果（SEER）数据库人群的研究
Gastroenterol Res Pract. 2019 Feb 24;2019:9683298. doi: 10.1155/2019/9683298. eCollection 2019.